1. Home
  2. IH vs GNLX Comparison

IH vs GNLX Comparison

Compare IH & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IH
  • GNLX
  • Stock Information
  • Founded
  • IH 1996
  • GNLX 2001
  • Country
  • IH China
  • GNLX United States
  • Employees
  • IH N/A
  • GNLX N/A
  • Industry
  • IH Other Consumer Services
  • GNLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • IH Real Estate
  • GNLX Health Care
  • Exchange
  • IH Nasdaq
  • GNLX Nasdaq
  • Market Cap
  • IH 88.8M
  • GNLX 85.0M
  • IPO Year
  • IH 2020
  • GNLX 2023
  • Fundamental
  • Price
  • IH $1.74
  • GNLX $4.31
  • Analyst Decision
  • IH
  • GNLX Strong Buy
  • Analyst Count
  • IH 0
  • GNLX 4
  • Target Price
  • IH N/A
  • GNLX $18.25
  • AVG Volume (30 Days)
  • IH 12.1K
  • GNLX 312.3K
  • Earning Date
  • IH 02-27-2025
  • GNLX 03-31-2025
  • Dividend Yield
  • IH 4.82%
  • GNLX N/A
  • EPS Growth
  • IH N/A
  • GNLX N/A
  • EPS
  • IH 0.28
  • GNLX N/A
  • Revenue
  • IH $134,002,994.00
  • GNLX $8,000.00
  • Revenue This Year
  • IH $15.90
  • GNLX N/A
  • Revenue Next Year
  • IH $8.64
  • GNLX N/A
  • P/E Ratio
  • IH $6.26
  • GNLX N/A
  • Revenue Growth
  • IH N/A
  • GNLX N/A
  • 52 Week Low
  • IH $1.47
  • GNLX $1.60
  • 52 Week High
  • IH $2.48
  • GNLX $9.79
  • Technical
  • Relative Strength Index (RSI)
  • IH 55.05
  • GNLX 75.11
  • Support Level
  • IH $1.60
  • GNLX $3.20
  • Resistance Level
  • IH $1.70
  • GNLX $4.23
  • Average True Range (ATR)
  • IH 0.09
  • GNLX 0.56
  • MACD
  • IH 0.01
  • GNLX 0.10
  • Stochastic Oscillator
  • IH 77.78
  • GNLX 95.73

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. The majority of iHuman Inc's revenue comes from mainland China.

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.

Share on Social Networks: